XML 22 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows provided by operating activities    
Net income $ 3,355 $ 3,196
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization 2,126 1,835
Share-based compensation 1,538 1,140
Bad debt expense 147 0
Loss on sale of property and equipment 576 0
Loss from discontinued operations, net of tax 1,436 0
Deferred taxes (313) 0
Tax benefit from release of valuation allowance 0 (1,889)
Change in assets and liabilities    
Accounts receivable (2,131) (2,238)
Contract assets (1,589) (1,106)
Inventory (1,419) (73)
Other current assets (1,982) (74)
Other long term assets 0 (339)
Accounts payable and accrued expenses (1,481) (114)
Contract liabilities (166) 747
Net cash provided by operating activities 97 1,085
Cash flows provided by/(used in) investing activities    
Acquisition of property and equipment (422) (501)
Intangible property costs (291) (192)
Proceeds from sale of property and equipment 403 0
Proceeds from sale of discontinued operations 600 0
Acquisition of General Photonics Corporation 0 (19,004)
Net cash provided by/(used in) investing activities 290 (19,697)
Cash flows provided by/(used in) financing activities    
Payments on finance lease obligations (39) (27)
Payments of debt obligations 0 (625)
Repurchase of common stock (329) (2,220)
Proceeds from the exercise of options and warrants 1,397 438
Net cash provided by/(used in) financing activities 1,029 (2,434)
Net increase/(decrease) in cash and cash equivalents 1,416 (21,046)
Cash and cash equivalents—beginning of period 25,006 42,460
Cash and cash equivalents—end of period 26,422 21,414
Supplemental disclosure of cash flow information    
Cash paid for interest 3 17
Cash paid for income taxes 2,000 735
Non-cash investing and financing activities    
Contingent liability for business combination 0 940
Dividend on preferred stock, 59,469 shares of common stock issuable for the nine months ended September 30, 2019 $ 0 $ 285